Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

Name: Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
Published: 2026
License: Public Domain

Beijing Biotech · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

breast cancer (locally advanced or metastatic), her2-positive breast cancer, triple-negative breast cancer (tnbc), car-nk; dual targeting, doptive cellular immunotherapy, her2 / erbb2, muc1, ror1, mesothelin, solid tumor, biomarker-guided cohort assignment, lymphodepletion

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 980809
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.